{
    "clinical_study": {
        "@rank": "62205", 
        "acronym": "M2W", 
        "brief_summary": {
            "textblock": "Peripheral muscle mass and strength are relevant indicators of COPD survival. Current\n      guidelines recommend to assess muscle strength only in muscle wasted patients. However, a\n      recent study reported quadriceps weakness without muscle wasting (Menon, M et al. Resp.\n      Res.2012, 13:119). Thus, these guidelines raise the risk to miss out some weak patients. In\n      clinical settings, fat-free-mass index (FFMI) is indicated as a simple index to assess\n      muscle wasting. We aimed at determining the prevalence of patients entering in pulmonary\n      rehabilitation (PR) a priori not eligible for muscle strength evaluation given the lack of\n      muscle wasting clinical signs."
        }, 
        "brief_title": "Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "COPD", 
        "condition_browse": {
            "mesh_term": [
                "Pulmonary Disease, Chronic Obstructive", 
                "Muscular Atrophy", 
                "Muscle Weakness", 
                "Paresis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who have got FFMI (bioimpedance)\n\n          -  Patients who have done quadriceps muscle strenght evaluation\n\n        Exclusion Criteria:\n\n          -  Patients without FFMI\n\n          -  Patients without quadriceps muscle strenght"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "COPD patients from \"Clinique du Souffle La vallonie\" and \"Clinique du Souffle La Solane\""
            }
        }, 
        "enrollment": {
            "#text": "138", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080936", 
            "org_study_id": "FVIE_M2W"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Experimental approaches", 
            "Peripheral muscle Keyword", 
            "Rehabilitation"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lodeve", 
                    "country": "France", 
                    "zip": "34700"
                }, 
                "name": "Clinique du Souffle La Vallonie"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Minist\u00e8re de l'Enseignement sup\u00e9rieur et de la Recherche", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Muscle wasting in COPD patient", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080936"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Muscle weakness in COPD patient", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "source": "Groupe Fontalvie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Groupe Fontalvie", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}